We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Chromos Announces Expansion of Pfizer Collaboration
News   Jan 12, 2006

Chromos will use its ACE System to develop a cell line for a Pfizer therapeutic protein product candidate.

READ MORE

Asuragen Targets Early Diagnosis and Treatment Outcome for Cancer Patients
News   Jan 12, 2006

Asuragen will leverage the RNA expertise developed by Ambion.

READ MORE

Akubio Announces Appointment of Business Development Director
News   Jan 12, 2006

Ian Campbell has been appointed as Business Development Director.

READ MORE

Wave Bioreactors Added to Macrogenics cGMP Manufacturing Facility
News   Jan 12, 2006

The Wave Bioreactors® will enable MacroGenics to produce monoclonal antibodies under cGMP standards.

READ MORE

Xencor and Roche Extend XmAb™ Antibody Therapeutics Collaboration
News   Jan 12, 2006

Roche and Xencor entered into this collaboration in January 2005, in which Roche applies Xencor's XmAb Fc domains.

READ MORE

Symphogen’s Success Attracts USD 25 Million Investment
News   Jan 12, 2006

The financing will be used to carry out clinical trials of Symphogen’s first product, anti-RhD.

READ MORE

Strand and ChemAxon Enter into Collaboration
News   Jan 12, 2006

Strand Life Sciences integrates ChemAxon’s JChem suite of software with admetis.

READ MORE

Several new Pharma Drug Delivery Evaluation Agreements for pSivida
News   Jan 12, 2006

pSivida has entered into agreements to evaluate its platform technology for pharmaceutical companies’ developmental compounds.

READ MORE

Scientists Make First Step Towards 'Holy Grail' of Crystallography
News   Jan 12, 2006

Scientists develop a theory concerning the design of porous materials for protein crystallization.

READ MORE

Roche and Amira Pharmaceuticals Announce Innovative Alliance Model
News   Jan 12, 2006

Research collaboration for targets in inflammatory diseases; option for Amira to license specified clinical compounds from Roche.

READ MORE